Total Funding
3
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 3 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
PepVax is a biotechnology company
- Mahesh Narayanan: President and CEOPast Role: Newchip Accelerator, Program Director - Series A
About the Company
PepVax, Inc. has developed a novel DNA-based drug delivery and development platform, called SMARTmid™, to make safer and more effective treatments inside the patient (Intusic™) using a “Trojan Horse” approach. The company is currently focusing on treatment efforts for COVID-19.